Dr Chandrashekara S Medical Director

Slides:



Advertisements
Similar presentations
Q4: Clinical Case Conference on Human Immunodeficiency Virus Chua, Kathleen S.
Advertisements

CLINICAL ADVANCES OF ANTI - TIF 1 Γ AUTOANTIBODY IN A HUNGARIAN MYOSITIS COHORT Melinda Nagy-Vincze 1, Zoltán Griger 1, Levente Bodoki 1, Zsuzsa Szankai.
IIM - Epidemiology Rare, estimated annual incidence 5-10/million, estimated prevalence ~ 60/million. PM and DM peak in prevalence in childhood (5- 15yrs)
Dyspnea and Rash Andres Quiceno, MD Rheumatology PHD.
Plain Films Radiographs PA and Lateral Views CT Chest.
Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80%  More in overlap  Low in IBM Defined antibodies:50%
ILDs Wael Batobara. Interstitial Lung Diseases It is a group of diseases that shares the same clinical & radiological presentations Prognosis depends.
IMACS History and Development of Myositis Clinical Trials Muscle Study Group September 21, 2010 Chester V. Oddis, MD University of Pittsburgh.
Vasculitis and connective tissue disease – just a taster!! The common and the rare!!
DIAGNOSIS of AUTOIMMUNE DISEASES Assos. Prof. Gülderen Yanıkkaya Demirel MD, PhD Yeditepe University School of Medicine Immunology Department, Medical.
Dr Shoaib Raza.   Immune reactions against self antigens  Affects 1% to 2% of US population  Requirements for an autoimmune disorder:  Presence of.
Idiopathic Inflammatory Myopathies
39 yr old female pt, unemployed from Bloemfontein Routine follow up at rheumatology Background history of hypertension Diagnosis of ? Mixed connective.
INFLAMMATORY MYOPTHIES
Rheumatoid Arthritis(RA)
DoH IVIG Workshop Update, neurology usage and outcomes measurement
SKELETAL MUSCLE PATHOLOGY. Normal skeletal muscle.
Classification of IMD Adult Polymyositis (PM)
Nephrology Diseases & Chemotherapy. Idiopathic Nephrotic Syndrome (NS) Caused by renal diseases that increase the permeability across the glomerular filtration.
Dr. M. A. SOFI MD; FRCP; (London); FRCPEdin;FRCSEdin.
History of ANA testing The LE cells In vitro damaged white cells are coated with “LE Factor” LE factor: a family of antibodies to nuclear constituents.
Sophie Marceau By: Amy Farrell, Sierra Pantaleo, Morgan Williams.
Katie DePlatchett, M.D. AM Report May 26, 2010 Inflammatory Myopathies.
Spondyloarthropathies. Introduction Spondyloarthropathy (Spondloarthritis) – Term for a group of chronic diseases – Affecting the joints of the spine.
Yuliarni Syafrita Bagian Neurolog FK Unand
Idiopathic Inflammatory Myopathies. The idiopathic inflammatory myopathies (IIM) are a heterogeneous group of disorders characterized by symmetric proximal.
ENDOCRINE MANIFESTATION OF MALAGNANCY PARANEOPLASTIC SYNDROME
CLINICAL MANIFESTATION OF SYSTEMIC SCLEROSIS
INFLAMMATORY MYOPTHIES
A Child with proximal weakness F.Ahmadabadi MD Child Neurologist.
Diffuse connective tissue diseases. Modern pictures are of clinic, diagnostics. Доц. Н.З.Ярема.
RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.
Idiopathic Inflammatory Myopathies; how significant is creatine kinase levels in diagnosis and prognosis? Case report and literature review Travis Sizemore.
C-Reactive Protein (CRP). CRP CRP is a serologic test which is used for diagnosis of Inflammations and Infections. CRP was so named because it was first.
Myositis Isabelle Delgado Per. 5.
Dr. Ashwin Kulkarni M.S.Ramaiah Medicial College Bangalore India
4. Rheumatologic conditions
Idiopathic Inflammatory Myositis
MYOSITIS (Infammatory Myopathies)
Fig 1: Skin thickening and sclerodactyly Fig 2: Digital tip ulcers
Sjogren’s syndrome.
Dr.Babur Salim Student in Rheumatology deptt. FFH
Rheumatoid Arthritis and Your Organs
Internist, Rheumatologist
ENDOCRINE MANIFESTATION OF MALAGNANCY PARANEOPLASTIC SYNDROME
“Mixed Connective Tissue Disease: Still Crazy After All These Years”
Systemic Lupus Erythematosis
3. AUTOIMMUNITY Immune Mechanisms Tolerance 4. Rheumatologic diseases
Poly myositis and dermatomyositis
Connective tissue disease are we managing properly
INFLAMMATORY MYOPTHIES
School of Allied Health & College of Applied Sciences and Arts
Acquired Myopathies January 30, 2017 Christina M. Ulane, MD, PhD
RHEUMATIC DISEASES: DEFINITIONS AND CLASSIFICATIONS Dr. Femi Adelowo, FMCP, FWACP,FACR,FRCP Edin FRCP Lond Professor of Medicine and Consultant Rheumatologist,
Diagnosis and Management of Immune-Mediated Myopathies
IL-12 and IL-23.
Diseases of skeletal muscle
Anti-Synthetase Syndrome
Dermatomyositis perifascicular pattern of involvement
NP D.P. Bx: 9/8/2017.
Respiratory MCNs - Interstitial lung diseases
Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment Recommendations  Floranne C. Ernste, MD,
Classification tree for subgroups of idiopathic inflammatory myopathies (IIMs). Classification tree for subgroups of idiopathic inflammatory myopathies.
Idiopathic Inflammatory Myositis
Figure 1 Analysis of inflammatory cells in muscle biopsies
IVIg Therapy. IVIg Therapy What are Immunoglobulins? Immunoglobulins, also known as antibodies, are proteins that bind specifically to antigens Immunoglobulin.
Myositis 101 for PM/DM/NM/ASyS
Dermatomyositis and polymyositis
Presentation transcript:

Current status of antibodies (Myositis Profile) in Inflammatory myositis. Dr Chandrashekara S Medical Director ChanRe Rheumatology & Immunology Center and Research

Introduction Idiopathic inflammatory myopathies (IIM) are a group of systemic diseases characterized by an immune mediated attack on skeletal muscle Characterized by Proximal muscle weakness Nonsuppurative inflammation of skeletal muscle Accompanied by extramuscular manifestations Arthritis, Skin lesions, ILD, Calcinosis, Nodules and vasculitis

Classification of Idiopathic Inflammatory Myopathy Dermatomyositis Juvenile Adult Polymyositis T cell mediated Eosinophilic Granulomatous Inclusion body myositis Overlap Syndrome Antisynthetase syndrome Cancer associated myositis

What is the role of these AA Epiphenomena or pathognomonic ?

Where do we stand

Prognosis- yes

How do we use it Ms X Muscle weakness from 3 month Joint pains Elevated SGPT/ OT normal GGT Elevated CPK ANA –ve Biopsy patient refusing

Case Ctd… Myositis profile Shows positive Jo 1 +++

Case Ctd… Evaluation for ILD Management plans Regular follow up for ILD

Myositis profile Mi -2 Myositis specific antibodies are useful in diagnosis and therapeutic management of poly/dermatomyositis. Anti Mi-2 is highly specific for dermatomyositis, found in 15-30% PM-Scl in 50-70% of overlap syndromes with SSc Jo-1 : prevalance is 25-55%. Associated with interstitial lung fibrosis. PL-7 & Pl-3 : prevalance is 3-6% and 3% respectively. Ku Jo-1 PL-12 PL-7 Ro-52 PM-Scl control

Thank you….